0
1

ASSESSING AND TREATING SUICIDAL BEHAVIORSA Quick Reference Guide

DOI: 10.1176/appi.books.9780890423370.111619
text A A A

Based on Practice Guideline for the Assessment and Treatment of Patients With Suicidal Behaviors, originally published in November 2003. A guideline watch, summarizing significant developments in the scientific literature since publication of this guideline, may be available.

+

A. Assessment of Patients With Suicidal Behaviors

  • Refer to Table 1 for circumstances in which suicide assessment may be indicated.

Table Reference Number
TABLE 1. Circumstances in Which a Suicide Assessment May Be Indicated Clinically
+

1. Conduct a thorough psychiatric evaluation.

  • Identify psychiatric signs and symptoms.
    • Determine the presence or absence of signs and symptoms associated with specific psychiatric diagnoses.
    • Identify specific psychiatric symptoms that may influence suicide risk, including aggression, violence toward others, impulsiveness, hopelessness, agitation, psychic anxiety, anhedonia, global insomnia, and panic attacks.
  • Assess past suicidal behavior, including intent of self-injurious acts.
    • For each attempt, obtain details about the precipitants, timing, intent, consequences, and medical severity.
    • Ascertain if alcohol and drugs were consumed before the attempt.
    • Delineate interpersonal aspects of the attempt in order to understand issues that culminated in the attempt (e.g., persons present at the time of the attempt or to whom the attempt was communicated).
    • Determine the patient's thoughts about the attempt (e.g., perception of potential for lethality, ambivalence toward living, visualization of death, degree of premeditation, persistence of suicidal ideation, and reaction to the attempt).
  • Review past treatment history and treatment relationships.
    • Review psychiatric history (e.g., previous and comorbid diagnoses, prior hospitalizations and other treatment, past suicidal ideation).
    • Review history of medical treatment (e.g., identify medically serious suicide attempts and past or current medical diagnoses).
    • Gauge the strength and stability of current and past therapeutic relationships.
  • Identify family history of suicide, mental illness, and dysfunction.
    • Inquire about family history of suicide and suicide attempts and psychiatric hospitalizations or mental illness, including substance use disorders.
    • Determine the circumstances of suicides in first-degree relatives, including the patient's involvement and the patient's and relative's ages at the time.
    • Determine childhood and current family milieu, including history of family conflict or separation, parental legal trouble, family substance use, domestic violence, and physical and/or sexual abuse.
  • Identify current psychosocial situation and nature of crisis.Consider acute psychosocial crises or chronic psychosocial stressors that may augment suicide risk (e.g., financial or legal difficulties; interpersonal conflicts or losses; stressors in gay, lesbian, or bisexual youths; housing problems; job loss; educational failure).
  • Appreciate psychological strengths and vulnerabilities of the individual patient.Consider how coping skills, personality traits, thinking style, and developmental and psychological needs may affect the patients' suicide risk and the formulation of the treatment plan.

+

2. Specifically inquire about suicidal thoughts, plans, and behaviors.

  • Refer to Table 2 for specific issues to address.

Table Reference Number
TABLE 2. Questions That May Be Helpful in Inquiring About Specific Aspects of Suicidal Thoughts, Plans, and Behaviors

  • Elicit the presence or absence of suicidal ideation.
    • Address the patient's feelings about living with questions such as "How does life seem to you at this point?" or "Have you ever felt that life was not worth living?" or "Did you ever wish you could go to sleep and just not wake up?"
    • Focus on the nature, frequency, extent, and timing of suicidal thoughts, and consider their interpersonal, situational, and symptomatic context.
    • Speak with family members or friends to determine whether they have observed behavior (e.g., recent purchase of a gun) or have been privy to thoughts that suggest suicidal ideation.
    • If the patient is intoxicated with alcohol or other substances when initially interviewed, the patient's suicidality will need to be reassessed at a later time.
  • Elicit the presence or absence of a suicide plan.
    • Probe for detailed information about specific plans for suicide and any steps that have been taken toward enacting those plans.
    • Determine the patient's belief about the lethality of the method, which may be as important as the actual lethality of the method.
    • Determine the conditions under which the patient would consider suicide (e.g., divorce, going to jail, housing loss) and estimate the likelihood that such a plan will be formed or acted on in the near future.
    • Inquire about the presence of a firearm in the home or workplace. If a firearm is present, discuss with the patient or a significant other the importance of restricting access to, securing, or removing this and other weapons.
  • Assess the patient's degree of suicidality, including suicidal intent and lethality of plan.Determine motivation for suicide, seriousness and extent of the patient's aim to die, associated behaviors or planning for suicide, and lethality of the method.
  • Recognize that suicide assessment scales have very low predictive values and do not provide reliable estimates of suicide risk.Nonetheless, they may be useful in developing a thorough line of questioning about suicide or in opening communication with the patient.

+

3. Establish a multiaxial diagnosis.

  • Note all current or past axis I or axis II diagnoses, including those that may currently be in remission.
  • Identify physical illnesses (axis III), since such diagnoses may also be associated with an increased risk of suicide.
  • Record psychosocial stressors (axis IV), which may be either acute or chronic. Consider the perceived importance of the life event for the individual patient.
  • Assess the patient's baseline and current levels of functioning (axis V).

+

4. Estimate suicide risk.

  • Identify factors that may increase or decrease the patient's level of risk.
    • The presence of a psychiatric disorder is the most significant risk factor.
    • Medical illness is also associated with increased likelihood of suicide. See Table 3 for specific medical conditions that have been associated with increased risk.
    • See Table 3 for additional factors that increase risk and Table 4 for protective effects.
    • Almost all psychiatric disorders have been shown to increase suicide risk (Table 5).

Table Reference Number
TABLE 3. Factors Associated With Increased Risk for Suicide
Table Reference Number
TABLE 4. Factors Associated With Protective Effects for Suicide
Table Reference Number
TABLE 5. Risk of Suicide in Persons With Previous Suicide Attempts and Psychiatric Disordersa
+

B. Psychiatric Management

+

1. Establish and maintain a therapeutic alliance.

  • Suicidal ideation and behaviors can be explored and addressed within the context of a cooperative doctor-patient relationship, with the ultimate goal of reducing suicide risk.
  • Taking responsibility for a patient's care is not the same as taking responsibility for the patient's life.

+

2. Attend to the patient's safety.

  • For patients in emergency or inpatient settings, consider ordering observation on a one-to-one basis or by continuous closed-circuit television monitoring until an assessment of risk can be completed or if the patient is deemed to be at significant suicide risk.
  • Remove potentially hazardous items from the patient's room (if inpatient), and secure the patient's belongings.
  • Consider screening patients for potentially dangerous items by searching patients or scanning them with metal detectors.

+

3. Determine a treatment setting.

  • Treat in the setting that is least restrictive yet most likely to prove safe and effective (Table 6).

Table Reference Number
TABLE 6. Guidelines for Selecting a Treatment Setting for Patients at Risk for Suicide or Suicidal Behaviors

  • Take into consideration the estimated suicide risk and the potential for dangerousness to others.
  • Reevaluate the optimal treatment setting and the patient's ability to benefit from a different level of care on an ongoing basis throughout the course of treatment.

+

4. Develop a plan of treatment.

  • Consider potential beneficial and adverse effects of each option along with information about the patient's preferences.
  • Address substance use disorders.
  • Provide more intense follow-up in the early stages of treatment to provide support and to rapidly institute treatment.
  • Review with outpatients guidelines for managing exacerbations of suicidal tendencies or other symptoms that may occur between scheduled sessions.

+

5. Coordinate care and collaborate with other clinicians.

  • Establish clear role definitions, regular communication among team members, and advance planning for management of crises.
  • Communicate with other caregivers, including other physicians providing treatment for significant general medical conditions or other mental health professionals who may be providing therapy. Establish guidelines for contact in the event of a significant clinical change.

+

6. Promote adherence to the treatment plan.

  • Establish a positive physician–patient relationship.
  • Create an atmosphere in which the patient feels free to discuss positive or negative aspects of the treatment process.

+

8. Reassess safety and suicide risk.

  • Repeat suicide assessments over time, because of the waxing and waning nature of suicidality (see Table 1 for settings and circumstances).
  • Repeat suicide assessments in inpatient settings at critical stages of treatment (e.g., with a change in level of privilege, abrupt change in mental state, and before discharge).
  • Reassess suicidality if the patient was intoxicated with alcohol or other substances when initially interviewed.

+

9. Monitor psychiatric status and response to treatment.

  • Monitoring is especially important during the early phases of treatment, since some medications may take several weeks to provide therapeutic benefit.
  • An early increase in suicide risk may occur as depressive symptoms begin to lift but before they are fully resolved.

+

10. Obtain consultation, if indicated.

  • Consultation may be of help in monitoring and addressing countertransference issues.
  • Consultation may be important in affirming the appropriateness of the treatment plan or suggesting other possible therapeutic approaches.

+

C. Specific Treatment Modalities

+

1. Somatic Therapies

  • The strong association between depressive disorders and suicide supports the use of antidepressants.
  • Long-term maintenance treatment with lithium salts in patients with recurring bipolar disorder and major depressive disorder is associated with substantial reductions in risk of both suicide and suicide attempts.
  • There is no established evidence of a reduced risk of suicidal behavior with any other"mood-stabilizing" anticonvulsant agents.
  • Reductions in the rates of suicide attempts and suicide have been reported in specific studies of patients with schizophrenia treated with clozapine. Other first- and second-generation antipsychotics may also reduce suicide risk, particularly in highly agitated patients.
  • Because anxiety is a significant and modifiable risk factor for suicide, use of antianxiety agents may have the potential to decrease this risk. However, benzodiazepines occasionally disinhibit aggressive and dangerous behaviors and enhance impulsivity, particularly in patients with borderline personality disorder.
  • ECT may reduce suicidal ideation, at least in the short term.

+

2. Psychotherapies

  • Clinical consensus suggests that psychosocial interventions and specific psychotherapeutic approaches are of benefit.

+

D. Documentation and Risk Management

+

1. General Issues Specific to Suicide

  • It is crucial for the suicide risk assessment to be documented in the medical record.
  • See Table 7 for general risk management considerations.

Table Reference Number
TABLE 7. General Risk Management and Documentation Considerations in the Assessment and Management of Patients at Risk for Suicide
+

2. Suicide Prevention Contracts

  • Reliance on a suicide prevention contract may falsely lower clinical vigilance without altering the patient's suicidal state.
  • If a suicide prevention contract is used, a patient's unwillingness to commit to the contract mandates reassessment of the therapeutic alliance and the patient's level of suicide risk.
  • Suicide prevention contracts are not recommended in emergency settings; with newly admitted and unknown inpatients; with agitated, psychotic, or impulsive patients; or when the patient is under the influence of an intoxicating substance.

+

3. Communication With Significant Others

  • If a patient is (or is likely to become) dangerous to him- or herself or to others and will not consent to interventions intended to reduce those risks, the psychiatrist is justified in attenuating confidentiality to the extent needed to address the safety of the patient and others.

+

4. Management of Suicide in One's Practice

  • If a patient dies by suicide, ensure that his or her records are complete.
  • Conversations with family members can be appropriate and can allay grief and assist devastated family members in obtaining help.
  • In speaking with survivors, care must be exercised not to reveal confidential information about the patient and not to make self-incriminating or self-exonerating statements.

+

5. Mental Health Interventions for Surviving Family and Friends After a Suicide

  • Suggest psychiatric intervention to family members and friends shortly after the death to reduce their risk for psychiatric impairment.
  • Consider referring surviving family members and friends to a survivor support group.

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Related Content
Articles
Books
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 1.  >
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 3.  >
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 43.  >
Dulcan's Textbook of Child and Adolescent Psychiatry > Chapter 4.  >
Dulcan's Textbook of Child and Adolescent Psychiatry > Chapter 9.  >
Topic Collections
Psychiatric News
APA Guidelines
 
  • Print
  • PDF
  • E-mail
  • Chapter Alerts
  • Get Citation